OneChain Immunotherapeutics
PrivateLast Round
Grant
Feb 29, 2024
Total Funding Raised
$14.91M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
OneChain Immunotherapeutics is a biotechnology company that develops CAR-T therapies for the treatment of oncological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OneChain Immunotherapeutics Comparables
Compare OneChain Immunotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wugen | 83% | |
| Gyala Therapeutics | 83% | |
| PersonGen BioTherapeutics | 79% |
OneChain Immunotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 29, 2024 | ||||
| Pre Seed | Jun 22, 2023 | ||||
| Grant | Feb 23, 2023 | ||||
| Seed | Jul 20, 2020 |
Key People
Founding team and executive leadership
OneChain Immunotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| CDTI Innvierte | Seed |
| Nara Capital | Pre Seed |
| Clave Capital | Pre Seed |
| Center for Technological Development and Innovation | Pre Seed, Seed |
| Invivo Partners | Pre Seed, Seed |
| Josep Carreras Leukaemia Foundation | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 111% MoM.
- Jun 23, 2026
Monthly visitors grew 419% MoM, from 165 to 857.
OneChain Immunotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OneChain Immunotherapeutics's valuation, stock price, and market status.
Is OneChain Immunotherapeutics a public or private company?
OneChain Immunotherapeutics is a private company.
What is the current stock price of OneChain Immunotherapeutics?
OneChain Immunotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is OneChain Immunotherapeutics worth (valuation)?
Valuation information for OneChain Immunotherapeutics is not publicly available.
Can I buy OneChain Immunotherapeutics stock?
OneChain Immunotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OneChain Immunotherapeutics's last funding round?
OneChain Immunotherapeutics's most recent funding round was Grant on February 29, 2024.
Who are the main investors in OneChain Immunotherapeutics?
Key investors in OneChain Immunotherapeutics include Invivo Partners.
Will OneChain Immunotherapeutics IPO soon?
No public IPO plans have been announced for OneChain Immunotherapeutics.
How can I track OneChain Immunotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OneChain Immunotherapeutics's secondary market activity and sign up for updates.